Expertise in
17
conditions

Dr. Ralph E. Bennett

Rheumatology
Arizona Arthritis & Rheumatology Associates P C.
4550 E Bell Rd Ste 172, 
Phoenix, AZ 
Accepting New Patients
Offers Telehealth
Referral may be required
Before you request
Expertise in
17
conditions
Arizona Arthritis & Rheumatology Associates P C.
4550 E Bell Rd Ste 172, 
Phoenix, AZ 

Overview

Ralph Bennett is a Rheumatologist practicing medicine in Phoenix, Arizona.

Dr. Bennett is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Rheumatoid Arthritis (RA), Fibromyalgia, Postmenopausal Osteoporosis, and Osteoporosis.

He is actively involved in clinical research, co-authoring 2 peer reviewed articles and participating in 5 clinical trials. Dr. Bennett is currently accepting new patients.

Specialties

Rheumatology

Licenses

Internal Medicine in AZ

Languages Spoken

English
French
Spanish

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Commonwealth Care Alliance
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
MercyCare
  • EPO
  • HMO
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
VibrantRx
  • MEDICARE PDP
  • OTHER MEDICARE
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 17 Less Insurance Carriers -

Locations

Arizona Arthritis & Rheumatology Associates P C.
4550 E Bell Rd Ste 172, Phoenix, AZ 85032

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A 5-Year Prospective Observational Registry to Assess Adverse Events of Interest and Effectiveness in Adults With Active, Autoantibody-Positive Systemic Lupus Erythematosus Treated With or Without BENLYSTA™ (Belimumab)
A 5-Year Prospective Observational Registry to Assess Adverse Events of Interest and Effectiveness in Adults With Active, Autoantibody-Positive Systemic Lupus Erythematosus Treated With or Without BENLYSTA™ (Belimumab)
Enrollment Status: Completed
Publish Date: March 20, 2026
Intervention Type: Other, Biological
A Phase 4, Multicenter, Open-label, Efficacy and Safety Trial of Pegloticase and Methotrexate Co-administered in Patients With Uncontrolled Gout Who Have Previously Received Pegloticase Monotherapy But Did Not Maintain a Serum Uric Acid Response
A Phase 4, Multicenter, Open-label, Efficacy and Safety Trial of Pegloticase and Methotrexate Co-administered in Patients With Uncontrolled Gout Who Have Previously Received Pegloticase Monotherapy But Did Not Maintain a Serum Uric Acid Response
Enrollment Status: Completed
Publish Date: June 27, 2024
Intervention Type: Drug, Biological
Study Drug: Pegloticase
Study Phase: Phase 4
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study Comparing GSK3196165 With Placebo and With Tofacitinib, in Combination With Methotrexate in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study Comparing GSK3196165 With Placebo and With Tofacitinib, in Combination With Methotrexate in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Enrollment Status: Completed
Publish Date: March 27, 2024
Intervention Type: Biological, Drug
Study Drugs: GSK3196165, Tofacitinib, Methotrexate, Folic acid
Study Phase: Phase 3
A Multi-centre Long-term Extension Study to Assess the Safety and Efficacy of GSK3196165 in the Treatment of Rheumatoid Arthritis
A Multi-centre Long-term Extension Study to Assess the Safety and Efficacy of GSK3196165 in the Treatment of Rheumatoid Arthritis
Enrollment Status: Terminated
Publish Date: February 07, 2024
Intervention Type: Drug, Biological
Study Drugs: Otilimab, csDMARD
Study Phase: Phase 3
A 24-week, Phase 3, Multicentre, Randomised, Double-blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Sarilumab, in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biological DMARDs and/or Janus Kinase Inhibitors
A 24-week, Phase 3, Multicentre, Randomised, Double-blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Sarilumab, in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biological DMARDs and/or Janus Kinase Inhibitors
Enrollment Status: Completed
Publish Date: July 17, 2023
Intervention Type: Drug, Biological
Study Drugs: GSK3196165, Sarilumab, csDMARDs
Study Phase: Phase 3
View 4 Less Clinical Trials

2 Total Publications

A multicentre, efficacy and safety study of methotrexate to increase response rates in patients with uncontrolled gout receiving pegloticase (MIRROR): 12-month efficacy, safety, immunogenicity, and pharmacokinetic findings during long-term extension of an open-label study.
A multicentre, efficacy and safety study of methotrexate to increase response rates in patients with uncontrolled gout receiving pegloticase (MIRROR): 12-month efficacy, safety, immunogenicity, and pharmacokinetic findings during long-term extension of an open-label study.
Journal: Arthritis research & therapy
Published: May 11, 2022
Similar Doctors
Expertise in
23
conditions
Expertise in
23
conditions
Referral may be required
Before you request

Arizona Arthritis And Rheumatology Associates

4550 E Bell Rd Ste 170, 
Phoenix, AZ 
 (0.1 miles away)
480-443-8400
Languages Spoken:
English, Arabic, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Nehad Soloman is a Rheumatologist practicing medicine in Phoenix, Arizona. Dr. Soloman is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Rheumatoid Arthritis (RA), Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections, MAGIC Syndrome, and Light Chain Deposition Disease (LCDD). Dr. Soloman is currently accepting new patients.

Expertise in
37
conditions
Dr. Ravi M. Bhalla
Rheumatology
Expertise in
37
conditions
Dr. Ravi M. Bhalla
Rheumatology
Referral may be required
Before you request

Valley Arthritis Care

13613 W Camino Del Sol Ste 4, 
Sun City West, AZ 
 (21.3 miles away)
623-815-2690
Languages Spoken:
English, Hindi, Punjabi, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Ravi Bhalla is a Rheumatologist practicing medicine in Sun City West, Arizona. Dr. Bhalla is highly rated in 37 conditions, according to our data. His clinical expertise encompasses Palindromic Rheumatism, Fibromyalgia, Rheumatoid Arthritis (RA), and Postmenopausal Osteoporosis. Dr. Bhalla is board certified in American Board Of Internal Medicine. Dr. Bhalla is currently accepting new patients.

Expertise in
35
conditions
Expertise in
35
conditions
Referral required
Before you request

Arthritis Consultants

12665 W Smokey Dr Ste 140, 
Surprise, AZ 
 (19.0 miles away)
623-219-4040
Languages Spoken:
English, Hindi, Tamil
See accepted insurances
Accepting New Patients
Offers Telehealth

Vijayabhanu Mahadevan is a Rheumatologist practicing medicine in Surprise, Arizona. Dr. Mahadevan is highly rated in 35 conditions, according to our data. Her clinical expertise encompasses Rheumatoid Arthritis (RA), Postmenopausal Osteoporosis, Osteoporosis, and Polymyalgia Rheumatica. Dr. Mahadevan is board certified in American Board Of Internal Medicine. Dr. Mahadevan is currently accepting new patients.

Frequently Asked Questions about Dr. Ralph E. Bennett

How do I make an appointment with Dr. Ralph E. Bennett?

You can book an appointment with Dr. Ralph E. Bennett by calling their office at 480-443-8400. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Ralph E. Bennett a top-rated expert for Rheumatoid Arthritis (RA)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Ralph E. Bennett is classified as an Distinguished expert for Rheumatoid Arthritis (RA), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Ralph E. Bennett specialize in?

While Dr. Ralph E. Bennett is a Rheumatology, they have specific expertise in Rheumatoid Arthritis (RA), Fibromyalgia, and Postmenopausal Osteoporosis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Rheumatology.

Does Dr. Ralph E. Bennett participate in research or clinical trials?

Yes. Dr. Ralph E. Bennett has published 2 articles and abstracts on conditions like Rheumatoid Arthritis (RA). You can view a list of Dr. Ralph E. Bennett's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Ralph E. Bennett accept my insurance?

Dr. Ralph E. Bennett accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 480-443-8400 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Bennett's expertise for a condition
ConditionClose
    View All 16 Advanced Conditions
    View All 17 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile